Beckman Coulter, Inc.
Beckman Coulter – Access hsTnI
The Access hsTnI assay provides the advanced diagnostic capabilities necessary for today’s clinical laboratory, which aid physicians in diagnosing at risk patients for acute myocardial infarction earlier and discharging non-acute patients faster.
In comparison to standard troponin assays, high-sensitivity assays demonstrate significantly improved precision at and below the 99th percentile upper reference limit (URL), allowing better discrimination of small differences in troponin values between serial measurements.
- Aids in rapid diagnosis of AMI and confidently excludes AMI in as little as one hour after patient presentation
- Provides optimal precision at concentrations about 10x lower than previous generation troponin assays. Improved precision at the clinical cutoff reduces chance of misclassifying patients in the Emergency Department